/

Empresas

Ge

No verificado

Genentech

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

92 Comunicados de prensa

Ver todos los comunicados de prensa

15/07/2026

Industria

Ciencia

Higiene alimentaria

Biotecnología

Medicina - Varios

Sanidad

Farmacéutica

Salud

Oncología

FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy

Fuente

Editor

1.00

0

07/07/2026

Biotecnología

Farmacéutica

Salud

Industria

Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC

Fuente

Editor

1.00

0

02/07/2026

Oncología

Salud

Biotecnología

Medicina - Varios

Farmacéutica

Industria

Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer

Fuente

Editor

1.00

0

30/06/2026

Industria

Ciencia

Higiene alimentaria

Medicina - Varios

Biotecnología

Salud

Farmacéutica

Sanidad

Óptica

FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)

Fuente

Editor

1.00

0

18/06/2026

Industria

Oncología

Higiene alimentaria

Salud

Medicina - Varios

Farmacéutica

Biotecnología

FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma

Fuente

Editor

1.00

0

11/06/2026

Industria

Oncología

Higiene alimentaria

Salud

Medicina - Varios

Farmacéutica

Biotecnología

FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer

Fuente

Editor

1.00

0

02/06/2026

Oncología

Higiene alimentaria

Salud

Medicina - Varios

Farmacéutica

Biotecnología

FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting

Fuente

Editor

1.00

0

01/06/2026

Eventos

Web y redes sociales

Salud

Medicina - Varios

Sanidad

Farmacéutica

Biotecnología

Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions

Fuente

Editor

1.00

0

19/05/2026

Eventos

Ferias y Congresos

Industria

Biotecnología

Farmacéutica

Salud

Oncología

Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer

Fuente

Editor

1.00

0

15/05/2026

Industria

Biología

Biotecnología

Higiene alimentaria

Salud

Farmacéutica

Oncología

Ciencia

Medicina - Varios

FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0